Arthritis: Medical Treatments

Department of Health and Social Care written question – answered on 8th January 2021.

Alert me about debates like this

Photo of Tan Dhesi Tan Dhesi Shadow Minister (Transport)

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 3 November 2020 to Question 103607 on Arthritis: Medical Treatments, whether his Department plans to make an assessment of the effect of the covid-19 outbreak on the treatment of arthritis.

Photo of Tan Dhesi Tan Dhesi Shadow Minister (Transport)

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 3 November 2020 to Question 103607 on Arthritis: Medical Treatments, for what reason they have not made that assessment.

Photo of Edward Argar Edward Argar Minister of State (Department of Health and Social Care)

While no specific assessment was made, NHS England and NHS Improvement rapidly convened a COVID-19 musculoskeletal (MSK) stakeholder group at the beginning of the pandemic, led by the MSK National Clinical Director, and involving a range of professional, charity and patient groups including the Arthritis and Musculoskeletal Alliance (ARMA) and Versus Arthritis. This led to the development of a self-management resource for patients, including those with arthritis, in managing their condition at home during the COVID-19 pandemic.

NHS England and NHS Improvement continue to collaborate with ARMA and Versus Arthritis, as well as other key stakeholders, to provide guidance, support and communication to the National Health Service for people with arthritis, both in the current context of the pandemic and in the restoration of services. This collaboration recently led to a rapid assessment of the challenges experienced by patients with arthritis during the pandemic.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.